Indeed, in a recent study, it has been suggested that in A+ individuals, subgroups compatible with mixed AD or with a significant load of white matter hyperintensities show “uncertainty” with p-tau levels, which may deviate from the pattern typically expected for AD, becoming abnormal later in the course of the disease and sometimes being lower than expected or marginal [44]. Here, MAPT is linked to Alzheimer disease.